Drugs / OPM-101
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07040436 | Sep 2025 → Sep 2027 expected | melanoma | Oncodesign Precision Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OPM-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07040436 ↗ |
| Route | Oral | “daily oral treatment with OPM-101” NCT07040436 ↗ |